Inventor · disambiguated record
Thomas Malefyt
Also filed as: MALEFYT THOMAS · MALEFYT THOMAS R
21 granted patents·6 pending applications·89 citations·filing 2005–2021
95Inventor score
Files withHELSINN HEALTHCARE SA16BIOTIE THERAPIES INC5MALEFYT THOMAS R3Biotie Therapies1CALDERARI GIORGIO1
Top patents by PatentIndex Score
27 records- 0192US8598219B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·8 claims
- 0292US7960424B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted Jun 14, 2011·16 cites·6 claims
- 0392US7947725B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted May 24, 2011·15 cites·2 claims
- 0492US7947724B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2005·Granted May 24, 2011·16 cites·14 claims
- 0591US8729094B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted May 20, 2014·5 cites·30 claims
- 0688US9125905B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 8, 2015·2 cites·9 claims
- 0787US8598218B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·11 claims
- 0887US8518981B2Liquid pharmaceutical formulations of palonosetronCALDERARI GIORGIO·Filed 2011·Granted Aug 27, 2013·11 cites·12 claims
- 0986US9173942B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Nov 3, 2015·2 cites·19 claims
- 1083US9066980B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Jun 30, 2015·3 cites·16 claims
- 1182US8168785B2Benzothiazole derivativesMALEFYT THOMAS R·Filed 2009·Granted May 1, 2012·4 cites·1 claims
- 1275US9308266B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Apr 12, 2016·1 cites·1 claims
- 1371US8212044B2Benzothiazole derivativesMALEFYT THOMAS R·Filed 2011·Granted Jul 3, 2012·1 cites·1 claims
- 1470US2018193262A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2017·Application pending·0 cites
- 1569US9457021B1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Granted Oct 4, 2016·0 cites·20 claims
- 1668US2017042807A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 1767US10314798B2Compositions and methods for treating Alzheimer's disease and Parkinson's diseaseBIOTIE THERAPIES INC·Filed 2017·Granted Jun 11, 2019·0 cites·23 claims
- 1867US9439854B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 13, 2016·0 cites·8 claims
- 1966US2021177783A1Compositions and methods for treating alzheimer's disease and parkinson's diseaseBIOTIE THERAPIES INC·Filed 2021·Application pending·0 cites
- 2064US2014039000A1Liquid pharmaceutical formulations of palonosetronMACCIOCCHI SIMONE·Filed 2013·Application pending·0 cites
- 2163US8501938B2Benzothiazole derivativesMALEFYT THOMAS R·Filed 2010·Granted Aug 6, 2013·1 cites·2 claims
- 2262US10973784B2Compositions and methods for treating Alzheimer's disease and Parkinson's diseaseBIOTIE THERAPIES INC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 2362US9457020B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Oct 4, 2016·0 cites·3 claims
- 2462US8735576B2Benzothiazole derivativesBIOTIE THERAPIES INC·Filed 2013·Granted May 27, 2014·0 cites·2 claims
- 2562US2016317440A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 2653US10653699B2Controlled-release tozadenant formulationsBIOTIE THERAPIES INC·Filed 2016·Granted May 19, 2020·0 cites·34 claims
- 2751US2021093639A1Controlled-release tozadenant formulationsBiotie Therapies·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Malefyt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →